Bret Hankey insider trades: Bone Biologics (BBLG) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bret reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 2, 2020 | BBLG | ↑ Buy | 195,000 | $1.00 | $195K | By Hankey Capital, LLC | Jan 17, 2020 (15d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Bret Hankey's insider trades
Bret Hankey is a director at Bone Biologics (BBLG). Since Jan 2, 2020, Bret has reported 1 open-market purchase worth $195K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BBLG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.